Cost Effectiveness of Apomorphine in the Treatment of Advanced Parkinson Disease in the UK and Germany- Results from a Multicounty Decision Analytic Model
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1824
https://www.valueinhealthjournal.com/article/S1098-3015(13)03729-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1662
First Page :
A622
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03729-7&doi=10.1016/j.jval.2013.08.1824